Compare HGBL & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HGBL | ICCM |
|---|---|---|
| Founded | 1937 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.9M | 45.5M |
| IPO Year | N/A | N/A |
| Metric | HGBL | ICCM |
|---|---|---|
| Price | $1.28 | $0.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $4.00 | $2.50 |
| AVG Volume (30 Days) | 86.8K | ★ 403.0K |
| Earning Date | 11-06-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $49,890,000.00 | $2,975,000.00 |
| Revenue This Year | $16.03 | $13.67 |
| Revenue Next Year | $5.33 | $38.55 |
| P/E Ratio | $14.80 | ★ N/A |
| Revenue Growth | ★ 0.02 | N/A |
| 52 Week Low | $1.21 | $0.59 |
| 52 Week High | $2.39 | $1.66 |
| Indicator | HGBL | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 40.20 | 41.99 |
| Support Level | $1.24 | $0.67 |
| Resistance Level | $1.39 | $0.72 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 38.89 | 62.50 |
Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.